Antioxidants for the Prevention and Treatment of Multiple Sclerosis
Bioactive Nutraceuticals and Dietary Supplements in Neurological and Brain Disease, Page: 341-353
2015
- 8Citations
- 30Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Book Chapter Description
Multiple sclerosis is a chronic, inflammatory, demyelinating neurodegenerative disease affecting the central nervous system. Although its etiology remains unknown, it has been hypothesized that a dysregulation of the immune response towards different environmental factors, including nutrition, can promote the disease in genetically predisposed individuals. Accumulating data indicate that oxidative stress can play a role in the pathogenesis and symptom development of MS. As a consequence, the intake of appropriate amounts of antioxidants, such as vitamin A, vitamin E, lipoic acid, and coenzyme Q10, through diet or supplementation can be a promising tool for reducing the risk and slowing the progression of the disease. However, data in literature are still inconclusive; well-designed clinical intervention and prospective studies are warranted in order to assess whether antioxidant intake, in combination with other conventional treatments, might be beneficial in the management of MS.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/B9780124114623000357; http://dx.doi.org/10.1016/b978-0-12-411462-3.00035-7; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=84942609108&origin=inward; https://linkinghub.elsevier.com/retrieve/pii/B9780124114623000357; http://linkinghub.elsevier.com/retrieve/pii/B9780124114623000357; http://api.elsevier.com/content/article/PII:B9780124114623000357?httpAccept=text/xml; http://api.elsevier.com/content/article/PII:B9780124114623000357?httpAccept=text/plain; https://dx.doi.org/10.1016/b978-0-12-411462-3.00035-7
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know